Clinical Trial Update: Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating biological therapy and gene therapy for children with recurrent or refractory neuroblastoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Biological therapy
• Gene Therapy

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED